The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

<div>Kaplan-Meier survival curves of progression-free survival in adenocarcinoma according to <i>EGFR</i> T790M status.</div>

BioMed Research International

fig5

Figure 5

Figure 5: The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China 

Figure 5 | The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China 